Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers
Multicenter Prospective Validation Study on the Prediction of In-hospital Mortality Using CU Prediction Model for Patients With Bleeding Peptic Ulcers
Sponsor: Chinese University of Hong Kong
Listed as NCT02245802, this observational or N/A phase trial focuses on Bleeding Peptic Ulcer and remains completed. Sponsored by Chinese University of Hong Kong, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Aug 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese University of Hong Kong
- Hiroshima City Asa Hospital, Hiroshima
- Mitoyo General Hospital
- National Taiwan University Hospital
- Okayama University
- Tokyo University
- Tsuyama Central Hospital, Okayama
For direct contact, visit the study record on ClinicalTrials.gov .